Ceftezole

Ceftezole (CAS No.: 26973-24-0) is a semi synthetic first generation cephem antibiotic of the cephalosporin class that is broadly used as a reference small molecule in microbiology and metabolic enzyme research, with a primary research category in anti infective mechanism studies and secondary utility in carbohydrate metabolism oriented screening due to reported alpha glucosidase inhibitory activity. As a beta lactam antibacterial scaffold, its canonical mechanism is consistent with inhibition of bacterial cell wall biosynthesis through interaction with penicillin binding proteins and consequent disruption of peptidoglycan cross linking in susceptible gram positive and gram negative organisms, while the reported alpha glucosidase related activity supports its use in enzyme level probing of glycosidic processing pathways in biochemical assay systems. Publicly summarized evidence describes antibacterial potency in organism dependent in vitro susceptibility formats and enzyme inhibitory effects that are generally interpreted within screening relevant concentration windows from micromolar to higher exposure ranges depending on strain background, assay substrate, and endpoint definitions, and where precise potency values are not uniformly reported across sources it is methodologically appropriate to benchmark activity relative to cephalosporin comparators and validated alpha glucosidase inhibitor controls under matched conditions. In practical research workflows, Ceftezole is commonly applied in bacterial growth inhibition panels, resistance phenotyping, target engagement studies linked to cell wall stress responses, and exploratory enzyme assays, and it may also be incorporated into cell based and animal based experimental designs for pharmacology and mechanism characterization, with concentrations or doses used in experiments typically determined by specific protocol architecture, model sensitivity, and study objectives.